SGMO
Sangamo Therapeutics·NASDAQ
--
--(--)
--
--(--)
SGMO Filings
Filing Date
Form Description
Form Type
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-06
Sangamo Therapeutics, Inc. (SGMO) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Sangamo Therapeutics, Inc. (SGMO) Q3 2025 Earnings Call Transcript
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-06
Form 8-K - Current report
Key Events
2025-11-06 · Key Events
Form 8-K - Current report
